? Despite the unique and impressive complexity of the higher-order members of the myrmicarin family of natural products and their established potential to serve as valuable leads for the study of chemical biology, these secondary metabolites have remained unanswered synthetic challenges for nearly a decade. The absence of a cohesive biosynthetic pathway accounting for their formation could potentially explain this state of affairs. In this proposal, a unifying biogenetic hypothesis is advanced which outlines a clear method to accomplish the synthesis of all these compounds from two key starting materials, one of which is a simpler member of the myrmicarin family. Carefully considered synthetic pathways to the proposed materials for this sequence, facilitated by a series of designed cascade reactions and new synthetic methodologies, will enable its evaluation. The overall significance of this work resides in its promise to establish presently missing biosynthetic links for the myrmicarin family, to provide both natural and designed molecules that can serve as tools for the study of chemical biology, and to contribute generally to the advancement of synthetic organic chemistry. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM071160-01
Application #
6789741
Study Section
Special Emphasis Panel (ZRG1-F04 (20))
Program Officer
Okita, Richard T
Project Start
2004-09-01
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
1
Fiscal Year
2004
Total Cost
$41,068
Indirect Cost
Name
Harvard University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138